News

Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...
Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” second quarter 2025 ...
Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 ...
Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for around $17.5 ...
Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A ...
Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter. The fund underperformed its benchmark, the MSCI World Index (net), in the second ...
Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.
Becton Dickinson stock (BDX): Signs point toward continued underperformance until early June 2027.
Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.
This was the stock's third consecutive day of losses.